3,380
Views
12
CrossRef citations to date
0
Altmetric
Editorial

What is the current value of fluorescence polarization assays in small molecule screening?

ORCID Icon & ORCID Icon
Pages 131-133 | Received 19 Aug 2019, Accepted 06 Dec 2019, Published online: 13 Dec 2019

References

  • Holenz J, Stoy P. Advances in lead generation. Bioorg Med Chem Lett. 2019;29:517–524.
  • Sittampalam GS, Grossman A, Brimacombe K, et al., editors. Assay guidance manual [Internet]. Bethesda (MD): Eli Lilly & Company and the National Center for Advancing Translational Sciences; 2004 [cited 2019 Oct 25]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK53196/
  • Owicki JC. Fluorescence polarization and anisotropy in high throughput screening: perspectives and primer. J Biomol Screen. 2000;5:297–306.
  • Hall MD, Yasgar A, Peryea T, et al. Fluorescence polarization assays in high-throughput screening and drug discovery: a review. Methods Appl Fluoresc. 2016;4:022001.
  • Zhang H, Wu Q, Berezin MY. Fluorescence anisotropy (polarization): from drug screening to precision medicine. Expert Opin Drug Discov. 2015;10:1145–1161.
  • Roehrl MHA, Wang JY, Wagner G. A general framework for development and data analysis of competitive high-throughput screens for small-molecule inhibitors of protein–protein interactions by fluorescence polarization. Biochemistry. 2004;43:16056–16066.
  • Roehrl MHA, Kang S, Aramburu J, et al. Selective inhibition of calcineurin-NFAT signaling by blocking protein–protein interaction with small organic molecules. Proc Natl Acad Sci. 2004;101:7554–7559.
  • Huber S, Casagrande F, Hug MN, et al. SPR-based fragment screening with neurotensin receptor 1 generates novel small molecule ligands. Karnik SS, editor. PLoS One. 2017;12:e0175842.
  • Rinken A, Lavogina D, Kopanchuk S. Assays with detection of fluorescence anisotropy: challenges and possibilities for characterizing ligand binding to GPCRs. Trends Pharmacol Sci. 2018;39:187–199.
  • Huang X. Fluorescence polarization competition assay: the range of resolvable inhibitor potency is limited by the affinity of the fluorescent ligand. J Biomol Screen. 2003;8:34–38.
  • Enkvist E, Vaasa A, Kasari M, et al. Protein-induced long lifetime luminescence of nonmetal probes. ACS Chem Biol. 2011;6:1052–1062.
  • Banks P, Gosselin M, Prystay L. Impact of a red-shifted dye label for high throughput fluorescence polarization assays of G protein-coupled receptors. J Biomol Screen. 2000;5:329–334.
  • Ströhl F, Wong HHW, Holt CE, et al. Total internal reflection fluorescence anisotropy imaging microscopy: setup, calibration, and data processing for protein polymerization measurements in living cells. Methods Appl Fluoresc. 2017;6:014004.
  • Kumar M, Lowery RG. A high-throughput method for measuring drug residence time using the transcreener ADP assay. SLAS Discov. 2017;22:915–922.
  • Copeland RA. The drug-target residence time model: a 10-year retrospective. Nat Rev Drug Discov. 2016;15:87–95.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.